Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early warning system using primary health care data in the post-COVID-19 pandemic era: Brazil nationwide case-study.
Cerqueira-Silva T, Oliveira JF, Oliveira VA, Florentino PTV, Sironi A, Penna GO, Ramos PIP, Boaventura VS, Barral-Netto M, Marcilio I. Cerqueira-Silva T, et al. Among authors: boaventura vs. Cad Saude Publica. 2024 Dec 20;40(11):e00010024. doi: 10.1590/0102-311XEN010024. eCollection 2024. Cad Saude Publica. 2024. PMID: 39775767 Free PMC article.
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Among authors: boaventura vs. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
Validation of the questionnaire of olfactory disorders (QOD) for the Brazilian population.
Bernardino ABCDS, Barreto-Filho MA, Pompeu AS, Andrade JDS, Azevedo ACA, Brasil MQA, Cedro M, Araújo C, Andrade N, Akrami K, Scussiatto HO, Boaventura VS, Fornazieri MA. Bernardino ABCDS, et al. Among authors: boaventura vs. Clinics (Sao Paulo). 2024 Jun 14;79:100414. doi: 10.1016/j.clinsp.2024.100414. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 38878322 Free PMC article.
Pathophysiology of chikungunya virus infection associated with fatal outcomes.
de Souza WM, Fumagalli MJ, de Lima STS, Parise PL, Carvalho DCM, Hernandez C, de Jesus R, Delafiori J, Candido DS, Carregari VC, Muraro SP, Souza GF, Simões Mello LM, Claro IM, Díaz Y, Kato RB, Trentin LN, Costa CHS, Maximo ACBM, Cavalcante KF, Fiuza TS, Viana VAF, Melo MEL, Ferraz CPM, Silva DB, Duarte LMF, Barbosa PP, Amorim MR, Judice CC, Toledo-Teixeira DA, Ramundo MS, Aguilar PV, Araújo ELL, Costa FTM, Cerqueira-Silva T, Khouri R, Boaventura VS, Figueiredo LTM, Fang R, Moreno B, López-Vergès S, Mello LP, Skaf MS, Catharino RR, Granja F, Martins-de-Souza D, Plante JA, Plante KS, Sabino EC, Diamond MS, Eugenin E, Proença-Módena JL, Faria NR, Weaver SC. de Souza WM, et al. Among authors: boaventura vs. Cell Host Microbe. 2024 Apr 10;32(4):606-622.e8. doi: 10.1016/j.chom.2024.02.011. Epub 2024 Mar 12. Cell Host Microbe. 2024. PMID: 38479396 Free PMC article.
Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015-18: a matched cohort study and self-controlled case series.
Cerqueira-Silva T, Pescarini JM, Cardim LL, Leyrat C, Whitaker H, Antunes de Brito CA, Brickley EB, Barral-Netto M, Barreto ML, Teixeira MG, Boaventura VS, Paixão ES. Cerqueira-Silva T, et al. Among authors: boaventura vs. Lancet Infect Dis. 2024 May;24(5):504-513. doi: 10.1016/S1473-3099(23)00739-9. Epub 2024 Feb 8. Lancet Infect Dis. 2024. PMID: 38342106 Free article.
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
Kallás EG, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, Infante V, Palacios R, de Lacerda MVG, Batista Pereira D, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Barral AMP, Boaventura VS, Ramos F, Elias Júnior E, Cassio de Moraes J, Covas DT, Kalil J, Precioso AR, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Nogueira ML. Kallás EG, et al. Among authors: boaventura vs. N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790. N Engl J Med. 2024. PMID: 38294972 Clinical Trial.
Combining Digital and Molecular Approaches Using Health and Alternate Data Sources in a Next-Generation Surveillance System for Anticipating Outbreaks of Pandemic Potential.
Ramos PIP, Marcilio I, Bento AI, Penna GO, de Oliveira JF, Khouri R, Andrade RFS, Carreiro RP, Oliveira VA, Galvão LAC, Landau L, Barreto ML, van der Horst K, Barral-Netto M; ÆSOP Collaborating Teams. Ramos PIP, et al. JMIR Public Health Surveill. 2024 Jan 9;10:e47673. doi: 10.2196/47673. JMIR Public Health Surveill. 2024. PMID: 38194263 Free PMC article.
Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria.
Sagay AS, Hsieh SC, Dai YC, Chang CA, Ogwuche J, Ige OO, Kahansim ML, Chaplin B, Imade G, Elujoba M, Paul M, Hamel DJ, Furuya H, Khouri R, Boaventura VS, de Moraes L, Kanki PJ, Wang WK. Sagay AS, et al. Among authors: boaventura vs. Int J Infect Dis. 2024 Feb;139:92-100. doi: 10.1016/j.ijid.2023.11.036. Epub 2023 Dec 4. Int J Infect Dis. 2024. PMID: 38056689 Free PMC article.
42 results